Ed Chlorped Jr (chlorpheniramine maleate) NDC 0485-0098

NDC codes

FDA NDC Directory

Product NDC (as listed)0485-0098Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00485-0098Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0485-0098-16	00485009816	473 mL in 1 BOTTLE, PLASTIC (0485-0098-16)Marketed from Mar 4, 2011

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ed Chlorped Jr
Generic name (nonproprietary): chlorpheniramine maleate
Active ingredients: Chlorpheniramine maleate — 2 mg/5mL
Dosage form: Liquid
Route: Oral
Labeler: EDWARDS PHARMACEUTICALS, INC.
Product type: Over-the-counter drug
Marketing category: Unapproved drug (other)
Marketing start: Mar 4, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 0485-0098_423e5c5d-39b6-c528-e063-6394a90aab81SPL ID 423e5c5d-39b6-c528-e063-6394a90aab81SPL set ID 4a5e5968-1930-465a-9b8c-45ed936a0e11RxCUI 1363306UNII V1Q0O9OJ9ZUPC 0304850098164
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400485009816 followed by a unit qualifier and the quantity

Package 00485-0098-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 28, 2025.

Indications (excerpt from the label)

Uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)